covid-19 vaccine reports

Pfizer submits data to FDA on COVID vaccine in young kids

Reading now: 489
www.cidrap.umn.edu

Pfizer and BioNTech submitted initial data from a phase 2/3 trial of their mRNA COVID-19 vaccine for children ages 5 to 11 years to the Food and Drug Administration (FDA), and said an application for emergency use authorization of the vaccine in that age-group will likely follow in the coming weeks.On Sep 20, the company shared promising results in children in that age range of two doses of the mRNA vaccine, which contains 10 micrograms (μg) of active ingredient, compared with 30 μg contained in the currently FDA-approved vaccine.

Pfizer said the company will have data on vaccines in children ages 6 months to 2 years, and 2 years to 5 years, as soon as the fourth quarter of 2021.Children under age 5 received a lower 3-μg dose for each

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA